The effective psychopharmacological treatment is an important issue for a good legal prognosis of violent offenders suffering from schizophrenia. Due to poor compliance long-term depot antipsychotics have a special position in the risk management of these patients. There are no recent studies on the influence of different long-term depot antipsychotics on acts of institutional violence. A group of offenders suffering from schizophrenia with long-acting haloperidol was compared with a second group with long-acting risperidone. Given a similar psychopathological level, the anti-aggressive effect of both antipsychotics was comparable.
Zusammenfassung:
Die effektive psychopharmakologische Behandlung ist ein Schlüssel für eine günstige Kriminalprognose von gewalttätigen Maßnahmepatienten mit Schizophrenie. Dabei haben aufgrund der für gewöhnlich schlechten medikamentösen Compliance antipsychotisch wirksame Depotpräparate einen herausragenden Stellenwert im Risikomanagement dieser Patientengruppe. Der Einfluss der unterschiedlichen Depotpräparate auf Zwischenfälle im Maßnahmevollzug, ein wichtiger Indikator für die Legalprognose nach der bedingten Entlassung, wurde bisher nicht ausreichend untersucht.
In einer retrospektiven Studie wurden zwei Samples verglichen, die auf langwirksames intramuskuläres Risperidon bzw. auf Haloperidol eingestellt waren. Bei gleicher psychopathologischer Ausgangslage erwiesen sich beide Präparate als gleichwertig in ihrer antiaggressiven Wirksamkeit.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Literatur
Freedman R (2003). Schizophrenia. N Engl J Med 349: 1738–1749
Saha S, Chant D, Welham J et al. A systematic review of the prevalence of schizophrenia. PLoS Medicine, 2:e141.doi:10.1371, 2005.
McGrath J, Saha S and Welham J et al. (2004). A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status and methodology. BMC Medicine 2: 1–22
Saha S, Chant D and McGrath J (2007). A systematic review of mortality in schizophrenia. Arch Gen Psychiatry 64: 1123–1131
Hawton K, Sutton L and Haw C et al. (2005). Schizophrenia and suicide: systematic review of risk factors. Br J Psychiatry 187: 9–20
Fazel S, Khosla V and Doll H et al. (2008). The prevalence of mental disorder among the homeless in Western countries: systematic review and meta-regression analysis. PLoS Medicine 5: 1670–1681
Böker W. Häer H(1973). Gewalttaten Geistesgestörter. Eine psychiatrisch-epidemiologische Untersuchung in der Bundesrepublik Deutschland. Berlin-Heidelberg-New York, Springer
Wallace C, Mullen PE and Burgess P (2004). Criminal offending in schizophrenia over a 25-year period marked by deinstitutionalization and increasing prevalence of comorbid substance use disorders. Am J Psychiatry 161: 716–727
Arseneault L, Moffitt TE and Caspi A et al. (2000). Mental disorders and violence in a total birth cohort: results from the Dunedin Study. Arch Gen Psychiatry 57: 979–986
Walsh E, Gilvarry C and Samele C et al. (2004). Predicting violence in schizophrenia: a prospective study. Schizophr Res 67: 247–252
Schanda H, Knecht G and Schreinzer D et al. (2004). Homicide and major mental disorders: a 25-year study. Acta Psychiatr Scand 110: 98–107
Schanda H (2006). Untersuchungen zur Frage des Zusammenhangs zwischen Psychosen und Kriminalitä/Gewalttägkeit: Studiendesigns, methodische Probleme, Ergebnisse. Fortschr Neurol Psychiat 74: 85–100
Walsh E, Buchanan A and Fahy T (2002). Violence and schizophrenia: examining the evidence. Br J Psychiatry 180: 490–495
Fazel S and Grann M (2006). The population impact of severe mental illness on violent crime. Am J Psychiatry 163: 1397–1403
Fazel S, Grann M and Carlström E et al. (2009). Risk factors for violent crime in Schizophrenia: a national cohort study of 13,806 patients. J Clin Psychiatry 70: 362–369
Fazel S and Låström N (2008). Increased risk of sexual offending in men with psychotic disorders. Evid Based Ment Health 11: 95
Hiday VA (1997). Understanding the connection between mental illness and violence. Int J Law Psychiatry 20: 399-417
Hodgins S (2000). The etiology and development of offending among persons with major mental disorders. In: Hodgins S (ed) Violence among the mentally ill. Effective treatment and management strategies. Dordrecht, Kluwer, S.89-116
Stompe T, Strnad A and Ritter K et al. (2006). Patterns of socialization in male schizophrenic offenders. Aust N Z J Psychiatry 40: 554–561
Soyka M and Ufer S (2002). Aggression bei Schizophrenien: Prävalenz, psychopathologische und soziodemographische Korrelate. Fortschr Neurol Psychiatr 70: 171–177
Stompe T, Ortwein-Swoboda G and Schanda H (2004). Schizophrenia, Delusional Symptoms and Violence: The Threat/Control-Override-Concept Re-examined. Schizophr Bull 30: 31–44
Putkonen A, Kotilainen I and Joyal CC et al. (2004) Comorbid personality disorders and substance use disorders of mentally ill homicide offenders: a structured clinical study on dual and triple diagnoses. Schizophr Bull 30: 59–72
Modestin J and Wuermle O (2005). Criminality in men with major mental disorder with and without comorbid substance abuse. Psychiatry Clin Neurosci 59: 25–29
Swartz MS, Swanson JW and Hiday VA et al. (1998). Violence and severe mental illness: The effects of substance abuse and nonadherence to medication. Am J Psychiatry 155: 226–231
Swartz MS, Swanson JW and Hiday VA et al. (1998). Taking the wrong drugs: the role of substance abuse and medication noncompliance in violence among severely mentally ill individuals. Soc Psychiatry Psychiatr Epidemiol 33: 75–80
Brooks JO (2001). Successful outcome using quetiapine in a case of treatment- resistant schizophrenia with assaultive behavior. Schizophr Res 50: 133–134
Chengappa KN, Vasile J and Levine J et al. (2002). Clozapine: its impact on aggressive behavior among patients in a state psychiatric hospital. Schizophr Res 53: 1–6
Swanson JW, Swartz MS and Elbogen EB et al. (2004). Reducing violence risk in persons with schizophrenia: olanzapine versus risperidone. J Clin Psychiatry 65: 1666–1673
Swanson JW, Swartz MS and Elbogen EB (2004). Effectiveness of atypical antipsychotic medications in reducing violent behavior among persons with schizophrenia in community-based treatment. Schizophr Bull 30: 3–20
Swartz MS, Swanson JW and Wagner RH et al. (2001). Effects of involuntary outpatient commitment and depot antipsychotics on treatment adherence in persons with severe mental illness. J Nerv Ment Dis 189: 583–592
Krakowski MI, Czobor P and Citrome L et al. (2006). Atypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder. Arch Gen Psychiatry 63: 622–629
Krakowski MI, Czobor P and Nolan KA (2008). Atypical antipsychotics, neurocognitive deficits, and aggression in schizophrenic patients. J Clin Psychopharmacology 28: 485–493
Stadtland C, Groß G and Seitz N et al. (2007). Einfluss von Olanzapin auf Zwischenfälle im Maßregelvollzug. J Neurol Neurochir Psychiatr 2: 36–40
Swanson JW, Swartz MS and Van Dorn RA et al. (2008). CATIE investigators. Comparison of antipsychotic medication effects on reducing violence in people with schizophrenia. Br J Psychiatry 193: 37–43
Garavan J, Browne S and Gervin M et al. (1998). Compliance with neuroleptic medication in outpatients with schizophrenia; relationship to subject response to neuroleptics; attitudes to medication and insight. Comprehens Psychiatry 39: 215–219
Schooler NR (2003). Relapse and rehospitalisation: comparing oral and depot antipsychotics. J Clin Psychiatry 64(Suppl 1): 14–17
Schanda H and Taylor P (2001). Aggressives Verhalten psychisch Kranker im stationän Bereich: Häigkeit, Risikofaktoren, Prävention. Fortschr Neurol Psychiatr 69: 443–452
Hare RD, Clark D and Grann M et al. (2000). Psychopathy and the predictive validity of the PCL-R: an international perspective. Behav Sci Law 18: 623–645
Hare RD (2006). Psychopathy: a clinical and forensic overview. Psychiatr Clin North Am 29: 709–724
Taylor PJ (1985). Motives for offending among violent and psychotic men. Br J Psychiatry 147: 491–498
Leucht S, Davis JM, Engel RR, Kissling W and Kane JM (2009). Definitions of response and remission in schizophrenia: recommendations for their use and their presentation. Acta Psychiatr Scand Suppl. 438: 7–14
Author information
Authors and Affiliations
Corresponding author
Additional information
Eingegangen am 6. Mai 2009, angenommen am 14. Mai 2009
Long-term depot antipsychotics and incidents in forensic psychiatric institutions
Rights and permissions
About this article
Cite this article
Stompe, T., Schanda, H. Der Einfluss von langwirksamen intramuskulär verabreichten Antipsychotika auf intramurale Zwischenfälle bei Maßnahmepatienten mit Schizophrenie. psychiatr. psychother. 5, 49–54 (2009). https://doi.org/10.1007/s11326-009-0049-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11326-009-0049-1